YAP1 and breast carcinoma: Additional studies are needed to determine the molecular mechanism on regulation of YAP1 mRNA levels by ERK1; however, our data firstly suggested that ERK1 expression might be used as biomarker for prediction the prognosis in patients with breast cancer.